Cepheid Europe SAS

Cepheid is an automated molecular diagnostics innovator, focused on the speed and accuracy of PCR testing, enabling a higher quality of care, lower costs, and improved outcomes. Cepheid is a key player in point of care testing (POCT) for multiple clinical applications including COVID-19, healthcare-associated infections (HAIs), sexual health, critical infectious disease, virology, and oncology. The European headquarters are located in Maurens-Scopont, France, with the manufacturing site based in Solna, Sweden.

Health Technology Assessment, In-Vitro Diagnostic / Medical Devices Regulations, Shaping Europe’s Digital Strategy, Horizon Europe, Green Deal, Supply Shortages, Cross-border Healthcare, European Health Union, HERA, EU4Health, Europe’s Beating Cancer Plan, COVID-19 pandemic, Pandemic Response Preparedness.

https://www.cepheid.com/

2

0.75

No lobbyists with EP accreditations

EU-related activities are conducted from the headquarters in France, as Cepheid does not have a public affairs office in Brussels.

Data not provided by Register Secretariat due to GDPR

Data not provided by Register Secretariat due to GDPR

Companies & groups